OK Biotech Co., Ltd. (TPE:4155)
Taiwan · Delayed Price · Currency is TWD 14.45
-0.15 (-1.03%)
Jul 30, 2026, 12:36 PM CST
OK Biotech Financials Overview
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 1,528 | 1,556 | 1,670 | 1,192 | 1,484 | 1,263 |
Revenue Growth | -11.70% | -6.81% | 40.11% | -19.65% | 17.42% | -14.89% |
Gross Profit Gross Profit Growth | 448.04 | 429.25 | 275.66 | 196.88 | 344.96 | 186.83 |
Operating Income Operating Income Growth | 146.52 | 107.89 | 57.21 | -12.06 | 101.81 | 8.09 |
Net Income Net Income Growth | 113.01 | 82.45 | 93.98 | 2.95 | 143.46 | 43.46 |
Earnings Per Share EPS Growth | 0.78 | 0.57 | 0.64 | 0.02 | 1.16 | 0.41 |
EPS Growth | 37.68% | -11.55% | 3119.04% | -98.28% | 182.57% | -68.83% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Patient Monitoring Equipment Patient Monitoring Equipment Growth | 1,769 | 1,804 | 1,886 | 1,208 | 1,493 | 1,267 |
Intersegment Intersegment Growth | -241.02 | -247.93 | -215.55 | -16.37 | -9.78 | -3.4 |
Total Total Growth | 1,528 | 1,556 | 1,670 | 1,192 | 1,484 | 1,263 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 317.98 | 327.06 | 290.5 | 365.34 | 636.64 | 644.64 |
Total Debt Total Debt Growth | 1,006 | 1,013 | 720.05 | 331.95 | 780.63 | 733.86 |
Net Cash (Debt) Net Cash Growth | -688.33 | -686.09 | -429.55 | 33.39 | -143.98 | -89.22 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -4.74 | -4.70 | -2.93 | 0.26 | -1.11 | -0.75 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 342.3 | 318.86 | 65.9 | 2.93 | 240.53 | 21.9 |
Capital Expenditures CapEx Growth | -322.79 | -409.14 | -376.69 | -429.68 | -286.84 | -79.06 |
Free Cash Flow Free Cash Flow Growth | 19.51 | -90.28 | -310.79 | -426.74 | -46.31 | -57.16 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 29.33% | 27.58% | 16.51% | 16.52% | 23.25% | 14.79% |
Operating Margin | 9.59% | 6.93% | 3.43% | -1.01% | 6.86% | 0.64% |
Pretax Margin | 9.22% | 6.67% | 7.61% | 0.67% | 11.84% | 3.65% |
Profit Margin | 7.40% | 5.30% | 5.63% | 0.25% | 9.67% | 3.44% |
FCF Margin | 1.28% | -5.80% | -18.61% | -35.80% | -3.12% | -4.52% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.300 | 0.300 | 0.300 | 0.300 | 1.115 | 0.907 |
Dividend Per Share Growth | 0% | 0% | 0% | -73.11% | 22.95% | -28.58% |
Dividend Yield | 2.01% | 2.07% | 1.49% | 1.23% | 4.89% | 4.90% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 18.62 | 24.87 | 32.00 | 1240.26 | 18.42 | 51.00 |
Forward PE | - | 16.30 | 16.30 | 16.30 | 16.30 | 16.30 |
PS Ratio | 1.35 | 1.32 | 1.80 | 3.07 | 1.78 | 1.76 |